Precipio Inc. (PRPO)
5.65
-0.01 (-0.18%)
At close: Apr 14, 2025, 3:38 PM
5.72
1.24%
After-hours: Apr 14, 2025, 05:21 PM EDT
-0.18% (1D)
| Bid | 4.27 |
| Market Cap | 8.5M |
| Revenue (ttm) | 17.92M |
| Net Income (ttm) | -4.29M |
| EPS (ttm) | -2.93 |
| PE Ratio (ttm) | -1.93 |
| Forward PE | 16.67 |
| Analyst | n/a |
| Ask | 6.03 |
| Volume | 29,315 |
| Avg. Volume (20D) | 10,132 |
| Open | 5.67 |
| Previous Close | 5.66 |
| Day's Range | 5.16 - 6.04 |
| 52-Week Range | 3.90 - 10.74 |
| Beta | 1.04 |
About PRPO
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the se...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jun 30, 2017
Employees 54
Stock Exchange NASDAQ
Ticker Symbol PRPO
Website https://www.precipiodx.com
9 months ago
+23.87%
Precipio shares are trading higher after the compa...
Unlock content with
Pro Subscription
